fda novavax - Search News

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

The Food and Drug Administration gave Covid vaccine manufacturers instructions on what next fall’s Covid vaccines should target on Thursday, signaling it would prefer that they update the strain in t...

STAT · 8h

· 4d · on MSN

FDA approves Novavax's COVID-19 vaccine with limitations

PharmExec · 2d

FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine

COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say

The House budget bill that narrowly passed in an early morning vote on Thursday would effectively put the brakes on a clean energy production boom in the United States spurred by subsidies enacted in ...

· 13h

· 18h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating their protein-based vaccine technology. The approval positions Novavax as the only non-mRNA COVID-19 vaccine with full FDA approval, offering a differentiated alternative amid growing mRNA fatigue.

CIDRAP12h

FDA vaccine advisers recommend sticking with JN.1 strain for next COVID vaccines

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage vaccine for COVID vaccines for the upcoming US respiratory virus season, though the experts didn't recommend a specific sublineage.

2don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

3don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.